Drugmaker Boehringer Ingelheim Pharmaceuticals Inc. is preparing to negotiate with Medicare on a price for its diabetes drug Jardiance, the company told Bloomberg Law Wednesday.
The contract is a part of 'Project NextGen,' an initiative by HHS to advance new vaccines and therapeutics for more durable protection against COVID-19 infection.
After Pfizer and Moderna hiked the prices of their Covid-19 vaccines this year, the federal government will now pay nearly three times more than it did previously for each dose.
Biogen, the iconic but embattled biotech firm, is shuttering Biogen Digital Health, its roughly 150-person group focused on using new types of data like those from mobile phones and smart watches, and ending a clinical trial being conducted with Apple early, STAT has learned.